Millennium UN Plaza Hotel

Hear from government regulators, in-house pharmaceutical counsel, and expert attorneys on the front lines of the complex antitrust issues currently facing brand name and generic pharmaceutical manufacturers and learn how to:

  • Structure reverse settlement payment agreements that align with FTC concerns
  • Negotiate mergers in the wake of Pfizer/Wyeth, Teva/Barr and the revised Guidelines
  • Comprehend the impact of Ovation on product acquisitions
  • Update life cycle management strategies, including product migration, authorized generics and tactics for follow-on biologic products Navigate increased overseas focus by global regulators
  • Work more effectively with the FtC by gaining greater understanding of how the Commission operates
  • Meet emerging pricing and distribution concerns following health care reform

Washington partner, John Roberti will be speaking. For more information about this event, please click here.